BR0112268A - Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda - Google Patents
Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìdaInfo
- Publication number
- BR0112268A BR0112268A BR0112268-1A BR0112268A BR0112268A BR 0112268 A BR0112268 A BR 0112268A BR 0112268 A BR0112268 A BR 0112268A BR 0112268 A BR0112268 A BR 0112268A
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- compound
- substituted metacycline
- pharmaceutical composition
- tetracycline
- Prior art date
Links
- -1 metacycline compound Chemical class 0.000 title abstract 3
- 229940042016 methacycline Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229930101283 tetracycline Natural products 0.000 title abstract 3
- 239000004098 Tetracycline Substances 0.000 title abstract 2
- 229960002180 tetracycline Drugs 0.000 title abstract 2
- 235000019364 tetracycline Nutrition 0.000 title abstract 2
- 150000003522 tetracyclines Chemical class 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 title 1
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical class C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 abstract 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
"COMPOSTO DE METACICLINA 13-SUBSTITUìDA, MéTODO PARA TRATAR UM ESTADO RESPONSIVO à TETRACICLINA EM UM MAMìFERO, COMPOSIçãO FARMACêUTICA, E, MéTODO PARA SINTETIZAR UM COMPOSTO DE METACICLINA 13-SUBSTITUìDA". São descritos compostos de metaciclina 13-substituída, métodos de tratamento de estados responsivos à tetraciclina, e composições farmacêuticas contendo compostos de metaciclina 13-substituída.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21658000P | 2000-07-07 | 2000-07-07 | |
PCT/US2001/020716 WO2002004405A2 (en) | 2000-07-07 | 2001-06-29 | 13-substituted methacycline compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112268A true BR0112268A (pt) | 2003-05-27 |
Family
ID=22807633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112268-1A BR0112268A (pt) | 2000-07-07 | 2001-06-29 | Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda |
Country Status (16)
Country | Link |
---|---|
EP (3) | EP1661883B1 (pt) |
JP (1) | JP2004502751A (pt) |
KR (1) | KR20030017609A (pt) |
CN (1) | CN1452611A (pt) |
AT (2) | ATE465989T1 (pt) |
AU (1) | AU2001271616A1 (pt) |
BR (1) | BR0112268A (pt) |
CA (1) | CA2415172A1 (pt) |
CZ (1) | CZ2003332A3 (pt) |
DE (1) | DE60141994D1 (pt) |
EA (1) | EA200300136A1 (pt) |
HR (1) | HRP20030092A2 (pt) |
HU (1) | HUP0301429A2 (pt) |
IL (1) | IL153674A0 (pt) |
MX (1) | MXPA03000036A (pt) |
WO (1) | WO2002004405A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5010284B2 (ja) | 2004-01-15 | 2012-08-29 | パラテック ファーマシューティカルズ インコーポレイテッド | テトラサイクリン化合物の芳香族a環誘導体 |
AU2005299294B2 (en) | 2004-10-25 | 2012-06-07 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
CN101967108B (zh) * | 2010-09-13 | 2013-06-19 | 苏春华 | 一种美他环素的衍生物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990331A (en) | 1956-11-23 | 1961-06-27 | Pfizer & Co C | Stable solutions of salts of tetracyclines for parenteral administration |
US2980584A (en) | 1957-10-29 | 1961-04-18 | Pfizer & Co C | Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation |
US3062717A (en) | 1958-12-11 | 1962-11-06 | Pfizer & Co C | Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation |
US3165531A (en) | 1962-03-08 | 1965-01-12 | Pfizer & Co C | 13-substituted-6-deoxytetracyclines and process utilizing the same |
US3183267A (en) * | 1962-09-06 | 1965-05-11 | Pfizer & Co C | 6-methylenetetracycline derivatives |
GB1108310A (en) * | 1964-04-30 | 1968-04-03 | Pfizer & Co C | Derivatives of 6-methylene-tetracycline and process for their preparation |
US3454697A (en) | 1965-06-08 | 1969-07-08 | American Cyanamid Co | Tetracycline antibiotic compositions for oral use |
NL6607516A (pt) | 1966-05-31 | 1967-12-01 | ||
DE1767891C3 (de) | 1968-06-28 | 1980-10-30 | Pfizer | Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat |
US3957980A (en) | 1972-10-26 | 1976-05-18 | Pfizer Inc. | Doxycycline parenteral compositions |
DE2442829A1 (de) | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
US4018889A (en) | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
US4126680A (en) | 1977-04-27 | 1978-11-21 | Pfizer Inc. | Tetracycline antibiotic compositions |
EP1666453A1 (en) * | 1999-09-14 | 2006-06-07 | Trustees Of Tufts College | Methods of preparing substituted tetracyclines with transition metal-based chemistries |
-
2001
- 2001-06-29 MX MXPA03000036A patent/MXPA03000036A/es unknown
- 2001-06-29 CN CN01815052A patent/CN1452611A/zh active Pending
- 2001-06-29 EA EA200300136A patent/EA200300136A1/ru unknown
- 2001-06-29 JP JP2002509073A patent/JP2004502751A/ja not_active Ceased
- 2001-06-29 AT AT05020365T patent/ATE465989T1/de not_active IP Right Cessation
- 2001-06-29 BR BR0112268-1A patent/BR0112268A/pt not_active Application Discontinuation
- 2001-06-29 EP EP05020365A patent/EP1661883B1/en not_active Expired - Lifetime
- 2001-06-29 CZ CZ2003332A patent/CZ2003332A3/cs unknown
- 2001-06-29 EP EP10160000A patent/EP2204361B1/en not_active Expired - Lifetime
- 2001-06-29 AU AU2001271616A patent/AU2001271616A1/en not_active Abandoned
- 2001-06-29 CA CA002415172A patent/CA2415172A1/en not_active Abandoned
- 2001-06-29 IL IL15367401A patent/IL153674A0/xx unknown
- 2001-06-29 KR KR10-2003-7000157A patent/KR20030017609A/ko not_active Application Discontinuation
- 2001-06-29 DE DE60141994T patent/DE60141994D1/de not_active Expired - Lifetime
- 2001-06-29 EP EP01950647A patent/EP1301465A2/en not_active Withdrawn
- 2001-06-29 WO PCT/US2001/020716 patent/WO2002004405A2/en not_active Application Discontinuation
- 2001-06-29 AT AT10160000T patent/ATE526308T1/de not_active IP Right Cessation
- 2001-06-29 HU HU0301429A patent/HUP0301429A2/hu unknown
-
2003
- 2003-02-07 HR HR20030092A patent/HRP20030092A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2204361B1 (en) | 2011-09-28 |
EP1661883A1 (en) | 2006-05-31 |
EA200300136A1 (ru) | 2003-06-26 |
DE60141994D1 (de) | 2010-06-10 |
HRP20030092A2 (en) | 2004-06-30 |
CZ2003332A3 (cs) | 2003-05-14 |
JP2004502751A (ja) | 2004-01-29 |
EP2204361A1 (en) | 2010-07-07 |
CN1452611A (zh) | 2003-10-29 |
WO2002004405A3 (en) | 2002-03-14 |
HUP0301429A2 (hu) | 2003-09-29 |
ATE465989T1 (de) | 2010-05-15 |
KR20030017609A (ko) | 2003-03-03 |
EP1661883B1 (en) | 2010-04-28 |
WO2002004405A2 (en) | 2002-01-17 |
ATE526308T1 (de) | 2011-10-15 |
MXPA03000036A (es) | 2003-07-14 |
EP1301465A2 (en) | 2003-04-16 |
IL153674A0 (en) | 2003-07-06 |
AU2001271616A1 (en) | 2002-01-21 |
CA2415172A1 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
BR9710768A (pt) | Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i | |
BR9811099A (pt) | Inibidores de urocinase | |
BR0109165A (pt) | Método de tratamento de pólipos colÈnicos | |
BR0115427A (pt) | Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
BR0109725A (pt) | Composto de tetraciclina substituìdo, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, método para sintetizar um composto de tetraciclina 7- ou 9-substituìdo, e, intermediário reativo | |
DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
NO963499L (no) | Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
BRPI0416909A (pt) | método de tratamento de aterosclerose | |
DE60022230D1 (de) | Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv | |
ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
WO2003039480A3 (en) | Method of treating disorder related to high cholesterol concentration | |
DE69729183T2 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
ATE334690T1 (de) | Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten | |
RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
DK1207870T3 (da) | Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf | |
SE0003476D0 (sv) | Compounds | |
BR9916255A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento de uma condição em que se requer inibição de trombina e para a preparação de compostos | |
BR0011339A (pt) | Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase | |
DE69613395D1 (de) | Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel | |
BR0312470A (pt) | Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto | |
BR0112268A (pt) | Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda | |
BR0112122A (pt) | Composto de rutênio (ii) , uso de um composto, composição farmacêutica, método para tratar e/ou prevenir o câncer, e, processo para preparar um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |